Creative BioMart has launched its large-scale GMP protein manufacturing service to support recombinant protein production for life science and biopharmaceutical research applications.

As demand for GMP-grade recombinant proteins continues to grow in biologics and protein-related research, scalable manufacturing platforms have become increasingly important for projects requiring controlled production conditions and large-scale output. In response to these research needs, Creative BioMart has expanded its GMP protein manufacturing capabilities through a service platform covering multiple stages of recombinant protein production.

According to the company, the platform supports gene synthesis, vector construction, protein expression, and GMP production as part of an integrated recombinant protein manufacturing workflow. The service is designed to support research projects requiring scalable protein production under GMP-compliant conditions.

“Large-scale GMP protein production is becoming increasingly important in biologics and recombinant protein research,” said a spokesperson from Creative BioMart. “Our service platform is designed to support researchers with scalable manufacturing solutions and multiple GMP-grade expression system options for different protein production requirements.”

Creative BioMart provides several GMP-grade protein expression systems, including:

l GMP-grade yeast protein expression system

l GMP-grade E. coli protein expression system

l GMP-grade baculovirus-insect cell protein expression system

l GMP-grade mammalian cell protein expression system

These expression platforms are intended to support different recombinant protein characteristics and research applications across various biologics-related fields.

The company also stated that its manufacturing workflows follow GMP regulations to support product quality and purity requirements during protein production. In addition, the large-scale manufacturing platform is designed to support increasing production demand and scale-up processing requirements associated with protein research and related development workflows.

Large-scale recombinant protein manufacturing continues to play an important role in biologics research, antibody-related studies, protein therapeutics research, and other protein-based applications. As research projects increasingly require scalable production capacity and standardized manufacturing environments, GMP-compliant protein biomanufacturing platforms remain an important component of modern life science research infrastructure.

Creative BioMart continues to expand its recombinant protein research and manufacturing services in response to evolving demands in protein science and biotechnology research. To know more detailed information, please visit https://gmp-proteins.creativebiomart.net/large-scale-gmp-protein-biomanufacturing-service.html.